QEEG-guided neurofeedback for recurrent migraine headaches
- PMID: 21309444
- DOI: 10.1177/155005941104200112
QEEG-guided neurofeedback for recurrent migraine headaches
Abstract
Seventy-one patients with recurrent migraine headaches, aged 17-62, from one neurological practice, completed a quantitative electroencephalogram (QEEG) procedure. All QEEG results indicated an excess of high-frequency beta activity (21-30 Hz) in 1-4 cortical areas. Forty-six of the 71 patients selected neurofeedback training while the remaining 25 chose to continue on drug therapy. Neurofeedback protocols consisted of reducing 21-30 Hz activity and increasing 10 Hz activity (5 sessions for each affected site). All the patients were classified as migraine without aura. For the neurofeedback group the majority (54%) experienced complete cessation of their migraines, and many others (39%) experienced a reduction in migraine frequency of greater than 50%. Four percent experienced a decrease in headache frequency of < 50%. Only one patient did not experience a reduction in headache frequency. The control group of subjects who chose to continue drug therapy as opposed to neurofeedback experienced no change in headache frequency (68%), a reduction of less than 50% (20%), or a reduction greater than 50% (8%). QEEG-guided neurofeedback appears to be dramatically effective in abolishing or significantly reducing headache frequency in patients with recurrent migraine.
Comment in
-
Clinical benefit to patients suffering from recurrent migraine headaches and who opted to stop medication and take a neurofeedback treatment series.Clin EEG Neurosci. 2011 Apr;42(2):VIII-IX. Clin EEG Neurosci. 2011. PMID: 21675594 No abstract available.
Similar articles
-
Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study.Behav Brain Funct. 2010 Feb 2;6:9. doi: 10.1186/1744-9081-6-9. Behav Brain Funct. 2010. PMID: 20205867 Free PMC article.
-
QEEG guided neurofeedback therapy in personality disorders: 13 case studies.Clin EEG Neurosci. 2009 Jan;40(1):5-10. doi: 10.1177/155005940904000107. Clin EEG Neurosci. 2009. PMID: 19278127
-
Pain characteristics of the acute migraine attack.Headache. 2006 Jun;46(6):942-53. doi: 10.1111/j.1526-4610.2006.00443.x. Headache. 2006. PMID: 16732840
-
Neurofeedback therapy in patients with acute and chronic pain syndromes--literature review and own experience.Przegl Lek. 2013;70(7):440-2. Przegl Lek. 2013. PMID: 24167944 Review.
-
Pediatric migraine.Neurol Clin. 2009 May;27(2):481-501. doi: 10.1016/j.ncl.2008.11.003. Neurol Clin. 2009. PMID: 19289227 Review.
Cited by
-
Effect of Volatile Organic Chemicals in Chrysanthemum indicum Linné on Blood Pressure and Electroencephalogram.Molecules. 2018 Aug 17;23(8):2063. doi: 10.3390/molecules23082063. Molecules. 2018. PMID: 30126122 Free PMC article.
-
Pilot study: is the fear response the same in anorexia nervosa as in controls?Eat Weight Disord. 2020 Feb;25(1):37-40. doi: 10.1007/s40519-018-0494-1. Epub 2018 Mar 14. Eat Weight Disord. 2020. PMID: 29542065
-
Neurofeedback: A Comprehensive Review on System Design, Methodology and Clinical Applications.Basic Clin Neurosci. 2016 Apr;7(2):143-58. doi: 10.15412/J.BCN.03070208. Basic Clin Neurosci. 2016. PMID: 27303609 Free PMC article.
-
Comparison of neurofeedback and transcutaneous electrical nerve stimulation efficacy on treatment of primary headaches: a randomized controlled clinical trial.Iran Red Crescent Med J. 2014 Aug;16(8):e17799. doi: 10.5812/ircmj.17799. Epub 2014 Aug 5. Iran Red Crescent Med J. 2014. PMID: 25389484 Free PMC article.
-
Remediating Intractable Headache: An Effective Nonpharmacological Approach Employing Infralow Frequency Neuromodulation.Front Hum Neurosci. 2022 Jul 8;16:894856. doi: 10.3389/fnhum.2022.894856. eCollection 2022. Front Hum Neurosci. 2022. PMID: 35874149 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
